Noema Pharma Competitors and Similar CompaniesClear all

Noema Pharma's competitors and similar companies include Cipla, UCB and Genentech.

	Noema Pharma Noema Pharma is a biotech company developing therapies to address disabling symptoms in orphan conditions of the brain and nervous system.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2019	Founding Date 1935	Founding Date 1928	Founding Date 1976
Type	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Basel, CH HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 36	Employees 27,764	Employees 9,052	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income €1.6b (FY, 2025)	Net income N/A